CCG is hosting a 1-day meeting focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists.
Short hands-on workshops in the morning will be followed by scientific presentations in the afternoon. The meeting will end with a social reception.
Please note that space is limited so early registration is recommended.
| 08:00-08:30 | Morning Coffee
Registration (check-in and badge pick-up) |
| 08:30-10:00 |
Pharmacophore Modeling / Docking / Fragment-based Design / Scaffold Replacement / R-Group Screening / Project Search / Protein-Ligand Interaction Fingerprints |
| 10:00-10:30 | Morning Break |
| 10:30-12:00 |
R-Group Profiles and Analysis / MOEsaic / MMP Analysis / Descriptor Calculations / Conformational Searching / Molecular Alignments / Pharmacophore Modeling and Searching / Diversity Analysis |
| 12:00-13:00 | Lunch Break |
| 13:00-13:25 | Registration (check-in and badge pick-up) |
| 13:25-13:30 |
| 13:30-14:00 |
Andreas Goutopoulos, Senior Director- Chemistry, EMD Serono, Inc. |
| 14:00-14:30 |
Matt Lucas, Director of Chemistry, Yumanity Therapeutics |
| 14:30-15:00 |
Chris Yates, Director of Medicinal Chemistry, Viamet Pharmaceuticals |
| 15:00-15:30 |
Al Ajamian, Director, Chemical Computing Group |
| 15:30-16:00 | Afternoon Break |
| 16:00-16:30 |
Sean Brown, Principal Scientist, Amgen |
| 16:30-17:00 |
Jörg Bentzien, Principal Scientist, FORMA Therapeutics, Inc. |
| 17:00-17:30 |
Ravi Kurumbail, Research Fellow, Pfizer |
| 17:30-18:00 |
Edward J. Hennessy, Associate Principal Scientist, AstraZeneca |
| 18:00-18:15 |
| 18:15-19:15 | Social Reception |
There is no cost to attend but pre-registration is required as seats are limited. Registrations will be processed and accepted on a first-come, first-serve basis.
